MAZE · Maze Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Third Rock Ventures IV, L.P. 10% Owner | ▼ Sell | Other | 4,473,958 Shares held | 11/4/2025 | View profile |
| Lim Jonathan E Chairman & CEO | ▼ Sell | Other | 307,956 Shares held | 2/3/2025 | View profile |
| Coloma Jason V Chief Executive Officer | ▼ Sell | Open Market | 191,447 Shares held | 10/1/2026 | View profile |
| Dandekar Atul CSBO | ▼ Sell | Open Market | 32,316 Shares held | 9/29/2026 | View profile |
| Charles J. Homcy Director | ▼ Sell | Gift | 31,113 Shares held | 5/4/2026 | View profile |
| Bachrodt Amy SVP, Finance | ▼ Sell | Open Market | 12,965 Shares held | 4/1/2026 | View profile |
| Courtney Phillips GC and Corp. Secretary | ▼ Sell | Open Market | 7,007 Shares held | 9/3/2026 | View profile |
| Richard H. Scheller Director | ▼ Sell | Open Market | 0 Shares held | 9/15/2025 | View profile |
| Catherine A. Sohn Director | ▼ Sell | Open Market | 0 Shares held | 1/7/2026 | View profile |
| Bernstein Harold President, R&D & CMO | ▼ Sell | Open Market | 0 Shares held | 10/1/2026 | View profile |
Transaction History
| Coloma Jason V | ▼ Sell | Open Market | 2,593 | $70K | 10/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 31,908 | $862K | 10/1/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 16,141 | $168K | 10/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 16,141 | $435K | 10/1/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 9/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 7,500 | $203K | 9/29/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 9,705 | $255K | 9/4/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 3,207 | $83K | 9/3/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 11,282 | $293K | 9/3/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 36 | $929 | 9/3/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 129 | $3K | 9/3/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 5,130 | $133K | 9/3/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 59 | $2K | 9/3/2026 |
| Courtney Phillips | ▼ Sell | Open Market | 1,990 | $52K | 9/3/2026 |
| Courtney Phillips | ▼ Sell | Open Market | 22 | $567 | 9/3/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 9,852 | $260K | 9/2/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 1,375 | $37K | 9/2/2026 |
| Courtney Phillips | ▼ Sell | Open Market | 1,738 | $46K | 9/2/2026 |
| Courtney Phillips | ▼ Sell | Open Market | 243 | $7K | 9/2/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 391 | $11K | 9/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 4,481 | $118K | 9/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 625 | $17K | 9/2/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 2,800 | $74K | 9/2/2026 |
| Coloma Jason V | ▲ Buy | Option Exercise | 50,000 | $0 | 9/1/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 16,141 | $168K | 9/1/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 20,000 | $0 | 9/1/2026 |
| Courtney Phillips | ▲ Buy | Option Exercise | 11,000 | $0 | 9/1/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 12,500 | $0 | 9/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 2,593 | $68K | 9/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 31,908 | $839K | 9/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 16,141 | $426K | 9/1/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 8/28/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 7,500 | $207K | 8/28/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 16,142 | $168K | 8/13/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 16,142 | $446K | 8/13/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 2,439 | $65K | 8/3/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 154 | $4K | 8/3/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 30,304 | $810K | 8/3/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 1,604 | $43K | 8/3/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 7/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 7,100 | $194K | 7/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 400 | $11K | 7/29/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 14,609 | $152K | 7/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 13,409 | $400K | 7/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 1,200 | $36K | 7/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 2,593 | $78K | 7/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 30,311 | $908K | 7/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 1,597 | $49K | 7/1/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 6/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 7,500 | $210K | 6/29/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 23,865 | $622K | 6/23/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 2,040 | $53K | 6/22/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 1,953 | $51K | 6/22/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 553 | $15K | 6/1/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 14,853 | $155K | 6/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 13,253 | $339K | 6/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 1,600 | $42K | 6/1/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 6,090 | $160K | 6/1/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 5/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 7,500 | $198K | 5/29/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 25,582 | $666K | 5/26/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 4,504 | $117K | 5/22/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 2,478 | $64K | 5/22/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 1,822 | $47K | 5/15/2026 |
| Coloma Jason V | ▼ Sell | Open Market | 116 | $3K | 5/15/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 15,000 | $156K | 5/14/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 15,000 | $393K | 5/14/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 8,320 | $87K | 5/4/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 5,985 | $62K | 5/4/2026 |
| Charles J. Homcy | ▼ Sell | Gift | 7,422 | $0 | 5/4/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 4/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 7,500 | $190K | 4/29/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 15,000 | $156K | 4/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 11,352 | $332K | 4/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 3,348 | $101K | 4/1/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 300 | $9K | 4/1/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 2,500 | $26K | 4/1/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 2,200 | $65K | 4/1/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 300 | $9K | 4/1/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 3/30/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 6,710 | $196K | 3/30/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 790 | $24K | 3/30/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 15,000 | $156K | 3/20/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 6,161 | $297K | 3/20/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 3,795 | $187K | 3/20/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 5,044 | $252K | 3/20/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 30,000 | $313K | 3/10/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 29,652 | $1.5M | 3/10/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 348 | $18K | 3/10/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 5,000 | $52K | 3/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 1,300 | $58K | 3/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 3,700 | $168K | 3/2/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 2/27/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 3,739 | $169K | 2/27/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 3,761 | $172K | 2/27/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 15,000 | $156K | 2/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 600 | $27K | 2/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 8,364 | $384K | 2/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 5,936 | $275K | 2/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 100 | $5K | 2/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 4,064 | $187K | 2/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 736 | $34K | 2/2/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 4,844 | $50K | 2/2/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 156 | $2K | 2/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 200 | $9K | 2/2/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 7,500 | $78K | 1/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 1,200 | $52K | 1/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 3,500 | $154K | 1/29/2026 |
| Dandekar Atul | ▼ Sell | Open Market | 2,800 | $126K | 1/29/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 2,497 | $26K | 1/22/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 2,503 | $26K | 1/22/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 5,000 | $228K | 1/22/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 25,156 | $262K | 1/7/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 25,156 | $1.0M | 1/7/2026 |
| Catherine A. Sohn | ▲ Buy | Option Exercise | 20,744 | $216K | 1/7/2026 |
| Catherine A. Sohn | ▲ Buy | Option Exercise | 2,895 | $30K | 1/7/2026 |
| Catherine A. Sohn | ▲ Buy | Option Exercise | 3,281 | $34K | 1/7/2026 |
| Catherine A. Sohn | ▼ Sell | Open Market | 26,920 | $1.1M | 1/7/2026 |
| Catherine A. Sohn | ▲ Buy | Option Exercise | 2,493 | $26K | 1/6/2026 |
| Catherine A. Sohn | ▼ Sell | Open Market | 2,493 | $96K | 1/6/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 412 | $4K | 1/5/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 412 | $16K | 1/5/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 4,796 | $50K | 1/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 2,405 | $93K | 1/2/2026 |
| Bachrodt Amy | ▼ Sell | Open Market | 2,595 | $103K | 1/2/2026 |
| Bernstein Harold | ▲ Buy | Option Exercise | 4,432 | $46K | 1/2/2026 |
| Bernstein Harold | ▼ Sell | Open Market | 4,432 | $179K | 1/2/2026 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 204 | $2K | 1/2/2026 |
| Dandekar Atul | ▲ Buy | Option Exercise | 100 | $1K | 12/30/2025 |
| Dandekar Atul | ▼ Sell | Open Market | 100 | $4K | 12/30/2025 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 2,395 | $25K | 12/30/2025 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 2,605 | $27K | 12/30/2025 |
| Bachrodt Amy | ▼ Sell | Open Market | 5,000 | $200K | 12/30/2025 |
| Bernstein Harold | ▲ Buy | Option Exercise | 45,000 | $469K | 12/29/2025 |
| Bernstein Harold | ▼ Sell | Open Market | 27,800 | $1.1M | 12/29/2025 |
| Bernstein Harold | ▼ Sell | Open Market | 17,200 | $704K | 12/29/2025 |
| Dandekar Atul | ▲ Buy | Option Exercise | 72,400 | $754K | 12/29/2025 |
| Dandekar Atul | ▼ Sell | Open Market | 66,365 | $2.7M | 12/29/2025 |
| Dandekar Atul | ▼ Sell | Open Market | 6,035 | $248K | 12/29/2025 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 124 | $1K | 12/29/2025 |
| Bachrodt Amy | ▲ Buy | Option Exercise | 9,876 | $103K | 12/29/2025 |
| Bachrodt Amy | ▼ Sell | Open Market | 9,400 | $381K | 12/29/2025 |
| Bachrodt Amy | ▼ Sell | Open Market | 600 | $25K | 12/29/2025 |
| Charles J. Homcy | ▼ Sell | Other | 1,489 | $0 | 11/19/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Other | 1,600,000 | — | 11/4/2025 |
| Charles J. Homcy | ▼ Sell | Gift | 28,423 | $0 | 10/23/2025 |
| Richard H. Scheller | ▼ Sell | Open Market | 20,744 | $464K | 9/15/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Other | 5,762,788 | $0 | 2/3/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Other | 950,800 | $0 | 2/3/2025 |
| Lim Jonathan E | ▼ Sell | Other | 37,724 | — | 2/3/2025 |
| Lim Jonathan E | ▼ Sell | Other | 270,232 | — | 2/3/2025 |
| Charles J. Homcy | ▼ Sell | Other | 8,807 | — | 2/3/2025 |
| Charles J. Homcy | ▼ Sell | Other | 20,717 | — | 2/3/2025 |
| Charles J. Homcy | ▼ Sell | Other | 7,422 | — | 2/3/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pompe Disease Market Expected to Grow Through 2036
A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.
Pompe Disease Market Expected to Grow Through 2036. A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.